Skip to content

A randomised double blind placebo controlled trial of radiofrequency neurotomy for the treatment of lumbar zygapophysial joint pain

A randomised double blind placebo controlled trial of radiofrequency neurotomy for the treatment of lumbar zygapophysial joint pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12608000365369
Enrollment
30
Registered
2008-07-25
Start date
2008-11-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

In most patients with chronic low back pain, the cause of their pain is unknown. As well, there are very few proven treatments for chronic low back pain, and none of the commonly used treatments are known to relieve pain completely. However, in a small proportion of patients, the source of pain can be traced to one or more small joints in the lumbar spine, called the zygapophysial joints – or “Z” joints for short. Pain from these joints can be relieved by sealing the small nerves that supply the joints. This is done using a probe inserted, under X-ray control, onto each of the nerves. The probe delivers a tiny heat-lesion that seals the nerve. In full, this procedure is called percutaneous lumbar medial branch radiofrequency neurotomy. In short, it is known as radiofrequency, or RF neurotomy. Lumbar RF neurotomy is not an experimental procedure. It has been used in Medicine for nearly 30 years. In Australia, it is recognized in having a Medicare item number. Doctors who use this procedure to treat their patients believe that it works. However, some commentators have questioned if the results of the operation are genuine. They believe that patients report relief because of non-specific effects of the procedure – such as the ceremony of having an operation, or because patients want it to work. They argue that it is not necessary actually to coagulate the nerves in order to achieve a beneficial effect. This argument arises because there has been no rigorous scientific studies of the procedure in the form of controlled trials. In a controlled trial, a computer indicates whether patients should undergo the real treatment or a sham treatment. A sham treatment is one which is just like the real treatment but differs in one critical respect. In the present study, the difference is that in the sham procedure not actually coagulated. If an operation works in such a study, the results obtained from the real treatment emerge as better than those obtained from the sham treatment. The difference in results indicates how powerful the real treatment is. However, if there is no difference in the results, any apparent effectiveness of the treatment is attributed to non-specific influences. Some controlled trials for lumbar RF neurotomy have been conducted, but in each instance the operators used techniques that have been shown to fail to coagulate the target nerves accurately. In the one study in which correct techniques were used, the investigators found that some 80% of patients obtained at least 60% relief of their pain, and 60% of patients obtained at least 80% relief, lasting for at least 12 months after treatment. But these results have been disregarded because the study was not controlled: it provided the real treatment but had no patients who underwent sham treatment. Because of the lack of convincing scientific evidence that lumbar RF neurotomy actually works, some insurance carriers have undertaken to deny this form of treatment to their clients. This has occurred both in the United States and in Australia. In response to the conflict between those doctors who believe that lumbar RF neurotomy works and those who believe it does not, the International Spine Intervention Society has provided funding for study of the procedure, to be conducted in which will look at recruiting 30 patient volunteers.

Interventions

Radiofrequency Neurotomy (RFN) involves the insertion of an insulated needle electrode (probe) with an exposed tip into contact or close proximity to a target nerve under local anaesthetic and radiological control. A RF generator applies current to raise the temperature of the exposed tip of the probe to 80-85 degrees celcius and maintained at that level for 90 seconds, in order to coagulate the target nerve and disrupt the conduction of nociceptive (pain producing) impulses along that nerve. Th

Radiofrequency Neurotomy (RFN) involves the insertion of an insulated needle electrode (probe) with an exposed tip into contact or close proximity to a target nerve under local anaesthetic and radiological control. A RF generator applies current to raise the temperature of the exposed tip of the probe to 80-85 degrees celcius and maintained at that level for 90 seconds, in order to coagulate the target nerve and disrupt the conduction of nociceptive (pain producing) impulses along that nerve. This outcome is acheived in one single treatment.

Sponsors

Dr. Paul Verrills
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Low back pain for a duration of more than 3 months 2. Pain severity of at least 5/10 on a visual analogue scale, which is sufficient to warrant invasive treatment 3. Complete, or vitually complete, relief of pain in response to controlled, medial branch blocks performed on at least two occasions. 4. Up to, but not exceeding two sympathetic zygapophysial joints per side

Exclusion criteria

1. Unable to provide informed consent 2. Unable to complete the assessment instruments 3. Anatomical abnormalities that might interfere with the safe conduct of the treatment 4. Any illness or disorder that might interfere with the safe conduct of treatment 5. Overt, clinically evident psychological disturbance, such as severe depression, drug dependence, or drug-seeking behaviour that might interfere with the assessment or response to treatment 6. Concomitant cervical, thoracic, hip, or other pain, of an intensity greater than 2/10 (on the visual analogue scale (VAS))or otherwise, which may interfere with the assessment or response to treatment

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026